Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Nokia Is a Cynical Beneficiary of the Trump Administration

For years, Nokia stock has been a frustrating investment. But with geopolitical tensions pressuring the telecom equipment industry’s top contender, NOK looks mighty interesting for the contrarian.

General Electric is Losing Credibility Amid Multiple Crises

GE stock was already a challenging recovery story before the pandemic. But with the coronavirus decimating air travel, this narrative became all the more difficult.

7 Stocks to Short Now to Make Big Money

Many publicly traded companies are moving higher simply off a rising tide. Thus, this is an ideal time to consider stocks to short.

IBIO Will Continue to Power Higher on Its Superior Scalability

IBIO stock is hardly alone as a direct play on the coronavirus vaccine industry. Nevertheless, the company separates itself from the muck with its proprietary ability to scale up solutions.

Moderna May Not Be What Speculators Thought

With demand sky-high for a coronavirus vaccine, it was only natural that MRNA stock jumped higher on Moderna’s encouraging early stage clinical trial results. However, its questionable practices are now coming into closer view.